Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up 0.34% Nasdaq Up 0.16%
Streaming
Ticker Tape: On

More On GWPRF

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates
  • Research Reports

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

GW Pharmaceuticals plc (GWPRF)

-OTC Markets

0.75 May 21, 3:06PM EDT|Pre-Market : NaN

Add to Portfolio
Prev Close:0.75
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.58 - 1.35
Volume:0
Avg Vol (3m):19,879
Market Cap:131.53M
P/E (ttm):25.86
EPS (ttm):0.03
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Reports

  • No Reports available for GWPRF at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.47
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

GW Pharmaceuticals plc, together with its subsidiaries, engages in the research, development, and commercialization of a range of cannabinoid prescription medicines. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback